hemodialysis/hemorrhage

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 5265 rezilta yo

Testing the outcome score of spontaneous intracerebral haemorrhage in haemodialysis patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The aim of this study is to determine the predictive value of the spontaneous intracerebral haemorrhage (ICH) outcome score (which we described previously) in haemodialysis (HD) patients who develop spontaneous ICH. The validation cohort consisted of all HD patients with spontaneous ICH presenting

Dialysis-induced worsening of cerebral edema in intracranial hemorrhage: a case series and clinical perspective.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Intracranial hemorrhage (ICH) is not an uncommon complication of end-stage renal disease (ESRD), and may be complicated by cerebral edema. Hemodialysis (HD) may induce rapid osmolar and fluid shifts, increasing brain water content with the potential to worsen cerebral edema. The dangers

Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Whether to anticoagulate dialysis patients with atrial fibrillation is a common clinical dilemma with limited high-quality data to inform decision-making. While the efficacy and safety of anticoagulation for stroke prevention in dialysis patients with atrial fibrillation has long been debated and

Performance of bleeding risk scores in dialysis patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to

Experience with ulcerated, bleeding autologous dialysis fistulas.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The incidence of ulcerated, bleeding, autologous, hemodialysis fistulas has been felt to be increasing in recent years. This review was undertaken to examine our experience with patients who presented with episodes of spontaneous bleeding in the presence of an ulcerated lesion over their

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Patients on chronic hemodialysis often have acquired coagulopathy that can aggravate bleeding from puncture site after needle extraction. Chitosan-based pads have been reported to accelerate hemostasis even in the presence of coagulopathy. The aim of this study was to evaluate the

Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Bleeding time, blood loss and platelet retention by glass beads, measured by standardized techniques, were significantly altered in a group of 30 non-thrombocytopenic patients with chronic renal failure undergoing maintenance haemodialysis. Bleeding time or blood loss did not correlate with platelet

Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Patients with atrial fibrillation who receive dialysis are at a high risk of ischemic stroke. The role of warfarin in mitigating this risk in patients with atrial fibrillation who receive dialysis is uncertain. Our objective was to examine the safety and efficacy of warfarin in patients who have

Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Blood loss from the access cannulation site during hemodialysis (HD) treatment is inevitable. Nevertheless, during HD, excessive blood loss from the cannulation site is not uncommon. The clinical characteristics associated with it and whether such blood loss could impact on patient outcomes is

Excessive Access Cannulation Site Bleeding Predicts Long-Term All-Cause Mortality in Chronic Hemodialysis Patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Our group has previously reported that excessive vascular access bleeding during dialysis treatment in stable hemodialysis (HD) patients was associated with anemia and may indicate poorer health. The association between excessive blood loss from access cannulation site and clinical outcomes was

Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Current observational studies on warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation (AF) undergoing dialysis found conflicting results. RESULTS We conducted a population-based retrospective cohort study of patients aged ≥65 years admitted to a hospital

Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The present paper describes a case of hemorrhagic cholecystitis in a patient on maintenance dialysis. The patient presented with right upper quadrant abdominal pain. Computed tomography revealed swelling of the gallbladder, high- and isodensity contents of the gallbladder, and high-density stone in

Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute kidney injury requiring renal replacement therapy occurs in up to 10% of all intensive care unit patients. Those who are hemodynamically unstable are often treated with continuous renal replacement therapy requiring continuous anticoagulation of the extracorporeal circuit. This is usually

A Multicenter Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND In 2014, the United States Food and Drug Administration approved a labeling change for apixaban to include recommendations for patients with severe renal impairment and patients with end-stage renal disease (ESRD) on hemodialysis (HD), though these recommendations are largely based on

Spontaneous renal hemorrhage in hemodialysis patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Dialysis patients have a tendency to bleed, and clinicians sometimes encounter cases with a significant amount of spontaneous hemorrhage. We herein report two cases of spontaneous renal hemorrhage in hemodialysis patients. CASE 1: A 70-year-old male who had received hemodialysis for 8 years

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye